O'Day Steven J 4
4 · AGENUS INC · Filed Jan 9, 2023
Insider Transaction Report
Form 4
AGENUS INCAGEN
O'Day Steven J
Chief Medical Officer
Transactions
- Award
Stock Option
2023-01-05+200,000→ 200,000 totalExercise: $2.45Exp: 2033-01-05→ Common Stock (200,000 underlying) - Award
Common Stock
2023-01-05$2.45/sh+109,381$267,983→ 272,384 total
Footnotes (3)
- [F1]Reflects the executive's 2022 performance bonus award paid in Agenus Stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 50% of the award released on March 24, 2023 and 50% of the award released on June 24, 2023.
- [F2]$2.45 was the fair market value of Agenus Common Stock on January 5, 2023, the stock issuance date.
- [F3]Option was granted on January 5, 2023 and awarded in accordance with the 2019 Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.